Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States

Fig. 1

Reasons for discontinuation of treatment prior to canakinumab: A Children and adults. Note: More than one reason per patient possible. N is the total number of patients in the respective category. Other reasons included ‘2 biologics’. B PFS subtypes. Note: More than one reason per patient possible. N is the total number of patients in the respective category. Other reasons included ‘2 biologics’. CAPS: cryopyrin-associated periodic syndromes; FMF, familial Mediterranean fever; HIDS: hyperimmunoglobulin D syndrome; MKD: mevalonate kinase deficiency; PFS: periodic fever syndrome; TRAPS: tumor necrosis factor receptor-associated periodic syndrome

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096